Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Khiron Life Sciences Corp (OP: KHRNF )

0.0310 -0.0025 (-7.46%)
Streaming Delayed Price Updated: 3:57 PM EDT, Jun 2, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 37,609
Open 0.0338
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0335
Today's Range 0.0310 - 0.0350
52wk Range 0.0123 - 0.1260
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Cannabis Movers & Shakers: Latest Appointments From Khiron, MariMed, Equilibria & More
Equilibria Strengthens Women's Wellness With New CSO 
Via Benzinga
Khiron Completes First Phase Of Business Optimization, Reduces Total Direct Labor Headcount By More Than 70% In Its Colombia SAS Subsidiary
Khiron Life Sciences Corp. (OTCQX: KHRNF) (TSXV:KHRN) (FSE:A2JMZC) completed its first phase of business optimization in Colombia, to focus on its high-margin B2C business model, centered around its... 
Via Benzinga

Performance

YTD
-27.91%
-27.91%
1 Month
N/A
N/A
3 Month
-58.22%
-58.22%
6 Month
-47.28%
-47.28%
1 Year
-71.56%
-71.56%

More News

Read More
This European City Wants To Legalize Marijuana, New Trial Launches This Summer
Via Benzinga
Khiron Snatches First Medical Cannabis Contract With One Of Colombia's Largest Insurance Companies
Via Benzinga
Khiron Q3 Revenue Declines 24% Sequentially To $2.5M
Via Benzinga
Khiron Appoints Helen Bellwood (ACA) As Interim CFO
Via Benzinga
Medical Cannabis Company Khiron Continues Global Expansion Into Spain
Via Benzinga
Khiron Life Sciences Raises C$4M Via Equity Offering
Via Benzinga
Khiron Launches Cannabis Flower Products In Switzerland
Via Benzinga
15 Global Psychedelics Executives To Keep An Eye On In 2022
Via Benzinga
Benzinga Cannabis Award Winners Announced At Chicago Conference, Check Out Full List
Via Benzinga
Marijuana Research Focuses Strictly On Potential Harms From THC, NCCIH Director Says
Via Benzinga
Medical Cannabis Company Khiron Launching New Products In Europe
Via Benzinga
Khiron Q2 Revenue Grows 60% YoY, Despite Decline In Medical Cannabis Sales In Germany
Via Benzinga
These 9 Cannabis Companies Are Leading The Way In Latin America: What Are They Up To And Why Should You Pay Attention?
Via Benzinga
Khiron Life Sciences Corp. (KHRNF) Featured in Coverage of Investor Summit Group’s Q3 Virtual Event
Via Investor Brand Network
Topics Cannabis
Exposures Cannabis
Cannabis Dispensary Roundup: Ascend Wellness, Berner's Cookies, Verano, Khiron, & EmporaPharma
Via Benzinga
Khiron Completes Acquisition Of Pharmadrug Production, Expanding Its Presence In Europe
Via Benzinga
Benzinga CEO Predicts $1B In Cannabis Deals Closing In Just 2 Days In September: Find Out Where And How!
Via Benzinga
Five Latinxs To Watch In The Cannabis Space: Meet The Who's Who At Benzinga's Cannabis Capital Conference In Chicago
Via Benzinga
This Week's Cannabis Career Moves: Khiron, Flora Growth, Agrify, Hempsmart And More
Via Benzinga
European Cannabis Q2 2022 Quarterly Update
Via Talk Markets
Meet Alvaro Torres, CEO Of Lat Am & UK's Top Medical Marijuana Brand At Benzinga's Cannabis Capital Conference In September
Via Benzinga
Khiron Reveals Results Of 2022 Annual General And Special Meeting
Via Benzinga
Khiron To Acquire EU-GMP-Certified German Pharmaceuticals Manufacturer And Wholesaler
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.